Exam 4 psych Flashcards
What are the questionnaires used for depression?
Patient Health care questionnaire (PHQ-9) & Beck depression inventory (BDI)
-both patient rated
Hamilton Depression (HAM-D, HDRS) & Montgomery-Asberg Depression Rating Scale (MADRS)
-both clinician rated (used in clinical trials)
What evidence exists for the Glutamate hypothesis in Schizophrenia?
Phenycyclidine and ketamine (inhibitors of NMDA) exacerbate psychosis and cognition deficits
What evidence exists for the Serotonin hypothesis in Schizophrenia?
5HT2a receptors are bad for schizophrenia; they modulate dopamine release, gluamate release and NMDA receptors
5HT2c recetors may be good for schizophrenia
What evidence exists for the dopamine hypothesis in Schizophrenia?
-strong correlation between binding affinity and clinical effectiveness of D2 receptor antagonists
-Dopaminergic agents (L-DOPA, amphetamine, bromocriptine) exacerbate schizophrenia symptoms
What drug induced movement disorders are associated with D2 antagonism?
Extrapyramidal Symptoms (EPS)
Tardive Dyskinesia
Neuroleptic Malignant Syndrome (NMS)
When do the movement disorders associated with D2 antagonism occur?
EPS- early, days/weeks, reversible
Tardive Dyskinesia- later, months/year, irreversible
Neuroleptic Malignant Syndrome- rapid, serious 10% fatality
What are the treatments for EPS associated with D2 antagonism?
Drug induced Parkinson’s- Benztropine, trihexphenidyl, diphenhydramine (Benedryl), Amantadine
Akathisia- propranolol
Acute Dystonia- IM benzotripine 2 mg, IM diphenhydramine 50 mg
What are the treatments for tardive dyskinesia associated with D2 antagonism?
Prevention
-low dose, less risky agents, newer agents
-VMAT inhibitors
*Tetrabenazine, Valbenazine, Deutetrabenazine
What are the treatments neuroleptic malignant syndrome associated with D2 antagonism?
-DA agonists, diazepam, dantrolene
-Discontinue drug asap
What is important to know about clozapine& monitoring?
agranulocytosis, risk of diabetes, QTc prolongation
monitoring timeline: weekly x6 months, biweekly x6 months, then every 4 weeks
What is important to know about Olanzapine?
weight gain, risk of diabetes, DRESS warning, sedation
What is the interaction between cigarette smoking and CYP1A2?
smoke induces 1A2 which decreases serum concentration of 1A2 substrate antipsychotics (olanzapine, asenapine, clozapine, loxapine)
What are the typical antipsychotics?
Haloperidol, Fluphenazine, Loxapine, Chlorpromazine, Perphenazine, Thioridazine
What are the atypical antipsychotics?
Aripiprazole, Asenapine, Brexpiprazole, Cariprazine, Clozapine, Iloperidone, Lumateperone, Lurasidone, Olanzapine, Paliperidone, Quetiapine, Risperidone, Ziprasidone
What are the partial agonist antipsychotics
-increased akathisia
-aripiprazole, Brexpiprazole, cariprazine
What is important to know about Quetiapine?
boxed warning for suicidal ideation, sedation, weight gain
What is important to know about Asenapine?
-SL and patch formulations
What antipsychotics have QTc prolongation?
Asenapine, Clozapine, Quetiapine, iloperidone, Ziprasidone (Contraindication), Paliperidone
What are the risperidone long-acting injections?
Risperdal Consta -3/4 weeks oral overlap
Perseris- abdonimal SC injection
Rykindo -1 week overlap (every 2 week IM injection)
Uzedy- can give every 1 or 2 months
What are the paliperidone long-acting injections?
Invega sustenna
Invega trinza
Invega Hafyera
What are the aripiprazole long-acting injections?
Abilify Maintena- overlap for 2 weeks; adjust dose if on 2D6 or 3A4 inhibitor/inducers
Abilify Asimtufii- overlap for 2 weeks; every 2 month dosing
Aristada- prodrug; overlap for 3 weeks
Aristada Initio- no overlap; avoid in poor 2D6 metabolizers & strong 3A4/2D6 inhibitors
What medications are used for psychiatric emergenices?
most common: Haloperidol
chlorpromazine, fluphenazine, Olanzapine IM (CI with benzo’s)
loxapine (inhalation formulation)
What is important to know about Lumateperone?
-newest agent
-lower risk for EPS, akathisisa, metabolic AE’s, 3A4 substrate
What is the indication for Pimaranserin?
hallucinations/delusions in a patient with parkison’s disease, 3A4 substrate